1-3 of 3
Gerald J. Roth
Close
Sort by
Journal Articles

Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups

Guido Bisping, Martin Kropff, Doris Wenning, Britta Dreyer, Sergey Bessonov, Frank Hilberg, Gerald J. Roth, Gerd Munzert, Martin Stefanic, Matthias Stelljes, Christian Scheffold, Carsten Müller-Tidow, Peter Liebisch, Nicola Lang, Jöelle Tchinda, Hubert L. Serve, Rolf M. Mesters, Wolfgang E. Berdel, Joachim Kienast
Journal: Blood
Blood (2006) 107 (5): 2079–2089.
https://doi.org/10.1182/blood-2004-11-4250
Published: 2006
Journal Articles

Enhanced Anti-Myeloma Activity by Combination of Receptor Tyrosine Kinase (RTK) Inhibition, Proteasome Inhibition, and Dexamethasone: Therapeutic Implications for t(4;14) and t(14;16) Multiple Myeloma (MM) Subgroups.

Guido Bisping, MD, Doris Wenning, Martin H. Kropff, MD, Gerd Munzert, MD, Frank Hilberg, PhD, Gerald J. Roth, PhD, Wolfgang E. Berdel, MD, Joachim Kienast, MD
Journal: Blood
Blood (2005) 106 (11): 112.
https://doi.org/10.1182/blood.V106.11.112.112
Published: 2005
Journal Articles

Human Signaling Protein 14-3-3ζ Interacts With Platelet Glycoprotein Ib Subunits Ibα and Ibβ

David C. Calverley, Terrance J. Kavanagh, Gerald J. Roth
Journal: Blood
Blood (1998) 91 (4): 1295–1303.
https://doi.org/10.1182/blood.V91.4.1295
Published: 1998